Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Algreen Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.001 |
52 Week High | €0.068 |
52 Week Low | €0.0002 |
Beta | -3.52 |
11 Month Change | -78.26% |
3 Month Change | -66.67% |
1 Year Change | -97.09% |
33 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
ALAVE | FR Consumer Retailing | FR Market | |
---|---|---|---|
7D | -50.0% | -0.7% | 0.4% |
1Y | -97.1% | -80.2% | 6.0% |
Return vs Industry: ALAVE underperformed the French Consumer Retailing industry which returned -80.2% over the past year.
Return vs Market: ALAVE underperformed the French Market which returned 6% over the past year.
Price Volatility
ALAVE volatility | |
---|---|
ALAVE Average Weekly Movement | 27.4% |
Consumer Retailing Industry Average Movement | 3.8% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.6% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALAVE's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALAVE's weekly volatility has decreased from 44% to 27% over the past year, but is still higher than 75% of French stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 7 | HA Hieu | algreen.fr |
Algreen, together with its subsidiaries, operates in agri-food industry in France and internationally. It is also involved in the production of smoked salmon, caviar, and salmon roe; and marketing distribution of a functional sparkling drink based on CBD to large retailers, cafes, hotels, restaurants, and out-of-home catering points of sale. The company was formerly known as Les Toques Blanches du Monde Société Anonyme and changed its name to Algreen in July 2022.
Algreen Fundamentals Summary
ALAVE fundamental statistics | |
---|---|
Market cap | €1.23m |
Earnings (TTM) | -€40.04m |
Revenue (TTM) | €6.04m |
0.2x
P/S Ratio0.0x
P/E RatioIs ALAVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALAVE income statement (TTM) | |
---|---|
Revenue | €6.04m |
Cost of Revenue | €6.27m |
Gross Profit | -€234.00k |
Other Expenses | €39.81m |
Earnings | -€40.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.033 |
Gross Margin | -3.88% |
Net Profit Margin | -663.12% |
Debt/Equity Ratio | -305.2% |
How did ALAVE perform over the long term?
See historical performance and comparison